The industry’s response to COVID-19 has made it clear that vaccines made right – meaning “safe, efficacious and readily available” – will find a market, whether or not they’re in the headlines.
We’re not looking to introduce incremental change; instead, our modular approach to next-generation vaccine manufacturing is designed to integrate novel biological, analytical or process-related technologies that can leapfrog the industry forward.
As your clinical and/or commercial supply partner in vaccine discovery and development, we will be teaming you with our experts in live viruses, viral vectors, oncolytic viruses and vectors, potency assays, and virus-like particles (VLP) and antigen vaccines. Our capabilities extend to our industry-leading expression systems, which are already proving their mettle in vaccines directed at public health threats.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |